Examining the practical significance of reporting patient deaths due to main disease progression.
Nickolai Usachev, MD
Advertisement
Articles by Nickolai Usachev, MD
Advertisement
Latest Updated Articles
Death Waivers Draw an Incomplete Picture of Drug SafetyPublished: August 18th 2015 | Updated:
- Death Waivers an Incomplete Picture of Drug Safety
Published: October 1st 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences
2
Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models
3
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
4
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
